2013 - Program Agenda

Wednesday - Thursday - Friday - Saturday

Wednesday, October 2, 2013

12:00pm - 1:30pm	Lunch Symposium (non-CME) Consider the Role of the Kidney in Type 2 Diabetes Mellitus Sponsored by Janssen Pharmaceuticals, Inc.	David S. H. Bell, MB
1:30pm - 2:45pm	Afternoon Symposium (non-CME) A Novel Treatment Option for Chronic Weight Management Sponsored by Eisai, Inc.	Robert J. Chilton, DO
2:45pm - 4:00pm	Afternoon Symposium A (non-CME) The Role of the Kidney in T2DM Pathophysiology Sponsored by Bristol-Myers Squibb and AstraZeneca LP	Paresh Dandona, MD
2:45pm - 4:00pm	Afternoon Symposium B (non-CME) AZORÂ® and TRIBENZORÂ®: Fixed-Dose Combination Therapy Sponsored by Daiichi Sankyo, Inc.	Robert Busch, MD
4:00pm - 5:15pm	Afternoon Symposium Cardiometabolic Risk in Racial/Ethnic Minorities: Unique Aspects and Practical Solutions Sponsored by the American College of Cardiology in collaboration with the National Minority Quality Forum and the Association of Black Cardiologists.	Keith C. Ferdinand, MD JoAnne Foody, MD Gary Puckrein, PhD Laurence Sperling, MD Tracy Wang, MD
5:15pm - 6:45pm	Early Evening Symposium (non-CME) Advancements in Cardiometabolic Risk Assessment: Expert Analysis of Recent Evidence and Outcomes Sponsored by Atherotech Diagnostics Lab	Eliot Brinton, MD Peter McCullough, MD, MPH Peter Toth, MD, PhD
7:00pm - 8:30pm	Dinner Symposium A (non-CME) Chronic Management of Obesity: The Role of a Unique, Once-Daily Treatment Sponsored by VIVUS, Inc.	W. Timothy Garvey, MD
7:00pm - 8:30pm	Dinner Symposium B (non-CME) KYNAMRO (mipomersen sodium) injection: An Overview for Clinicians Sponsored by Genzyme, A SANOFI COMPANY	Sotirios Tsimikas, MD

Thursday, October 3, 2013

6:15am - 7:45am	Breakfast Symposium A State-of-the-Art Antiplatelet Therapy for Patients with ACS: Expert Analysis & Evidence-Based Guidelines for Optimizing Patient Outcomes Supported by an educational grant from AstraZeneca	Deepak L. Bhatt, MD, MPH Robert Harrington, MD E. Magnus Ohman, MD Marc Sabatine, MD, MPH
6:15am - 7:45am	Breakfast Symposium B New Strategies for Obesity Management & Cardiometabolic Risk Reduction: Expert Perspectives on Novel Therapies Targeting the CNS Supported by an educational grant from Eisai, Inc.	Louis Aronne, MD Harold Bays, MD Lee M. Kaplan, MD, PhD Steven Smith, MD
8:00am - 8:10am	Opening Remarks	Christie Ballantyne, MD
8:10am - 8:50am	Keynote Session: Inflammation & Cardiometabolic Risk	Peter Libby, MD
8:50am - 10:00am	Late-Breaking Clinical Trials & FDA Update	Moderator: Christie Ballantyne, MD Presenters & Discussants: Deepak L. Bhatt, MD, MPH Robert Eckel, MD Keith C. Ferdinand, MD Jay Skyler, MD, MACP
10:00am - 11:00am	Morning Break/Exhibit Hall Sponsored by Takeda Pharmaceuticals U.S.A., Inc.
11:00am - 12:00pm	Hot Topics in ACS: Debate	Moderator: Deepak L. Bhatt, MD, MPH Presenters & Discussants: Robert Harrington, MD Daniel Simon, MD
12:15pm - 1:45pm	Lunch Symposium A Triglyceride & Mixed Dyslipidemia Management: Expert Analysis of Cutting-Edge Data & Evidence-Based Recommendations for Reducing Residual CV Risk Supported by an educational grant from Amarin Pharma, Inc.	Christie Ballantyne, MD Harold Bays, MD Deepak L. Bhatt, MD, MPH Sergio Fazio, MD, PhD Terry Jacobson, MD
12:15pm - 1:45pm	Lunch Symposium B Alternate Pathways for the Management of Type 2 Diabetes: Expert Analysis on Targeting Dopamine & the CNS for Glycemic Control & CV Risk Reduction Supported by an educational grant from Santarus, Inc.	David S. H. Bell, MB Samuel Dagogo-Jack, MD J. Michael Gaziano, MD, MPH Jay Skyler, MD, MACP
12:15pm - 1:45pm	Lunch Symposium C Personalized SIHD Management: Evidence-Based Decision Making for Patients at Increased Cardiometabolic Risk Supported by an independent educational grant from Gilead Sciences, Inc.	JoAnne Foody, MD Robert Harrington, MD Mikhail Kosiborod, MD David Morrow, MD, MPH
2:00pm - 2:45pm	Keynote Session: Translating Insights from Human Genetics into Novel Therapies for Dyslipidemia	Daniel Rader, MD
2:45pm - 3:30pm	Biomarkers vs. Imaging for CV Risk Assessment and Treatment: Debate	Moderator: Christie Ballantyne, MD Presenters & Discussant: Matthew Budoff, MD Paul Ridker, MD
3:30pm - 4:15pm	Afternoon Break/Exhibit Hall
4:15pm - 5:15pm	Clinical Controversies in Lipid Management: Case-Based Presentations & Discussion	Moderator: Christie Ballantyne, MD Presenters: Harold Bays, MD Robert Eckel, MD JoAnne Foody, MD
5:15pm	Closing Remarks	Christie Ballantyne, MD
5:30pm - 6:30pm	Welcome Reception
7:00pm - 9:00pm	Dinner Symposium A The Next-Generation of Weight-Loss Medications: Expert Recommendations for Managing Obesity, Diabetes & Cardiometabolic Risk Supported by an educational grant from VIVUS, Inc.	Robert Eckel, MD W. Timothy Garvey, MD Samuel Klein, MD Robert Kushner, MD Arya Sharma, MD, PhD
7:00pm - 9:00pm	Dinner Symposium B Personalized T2DM Management: The Role of Incretin Therapies Along the Continuum of Care This activity is supported by an independent medical education grant from Bristol-Myers Squibb and AstraZeneca, LP	Robert Chilton, DO Richard Pratley, MD Benjamin Scirica, MD Carol Wysham, MD

Friday, October 4, 2013

6:15am - 7:45am	Breakfast Symposium A Next-Generation Vasodilating Beta Blockers Along the HTN Continuum of Care: Expert Recommendations for Targeting Endothelial Dysfunction, BP, and Cardiometabolic Risk Supported by an educational grant from Forest Laboratories, Inc.	George Bakris, MD Keith C. Ferdinand, MD Thomas Giles, MD Michael Weber, MD
6:15am - 7:45am	Breakfast Symposium B State-of-the-Art Management of Severe and Familial Hypercholesterolemia: Examining the Role of Antisense Therapy in Clinical Practice Supported by an educational grant from Genzyme, A SANOFI COMPANY	P. Barton Duell, MD Peter Jones, MD Patrick Moriarty, MD Evan Stein, MD, PhD
8:00am - 8:10am	Opening Remarks	Jay Skyler, MD, MACP
8:10am - 8:40am	Personalized Diabetes Management: Selecting the Right Therapy	John Buse, MD, PhD
8:40am - 9:10am	Insulin Therapy: The State-of-the-Science	Irl Hirsch, MD
9:10am - 9:50am	T1DM 2013: Translating the Latest Advances into Clinical Practice	Robert Eckel, MD Jay Skyler, MD, MACP
9:50am - 10:50am	Morning Break/Exhibit Hall
10:50am - 11:30am	Pediatric Obesity & T2DM	Moderator: Jay Skyler, MD, MACP Presenters: Sonia Caprio, MD David Ludwig, MD
11:30am - 12:15pm	Diabetes Panel Discussion & Audience Q&A	Moderator: Jay Skyler, MD, MACP Discussants: John Buse, MD Sonia Caprio, MD Robert Eckel, MD Irl Hirsch, MD David Ludwig, MD
12:30pm - 2:00pm	Lunch Symposium A Advances in Basal Insulin Therapy: Expert Analysis of Novel Formulations, Combination Therapies & Delivery Technologies Supported by an educational grant from Novo Nordisk, Inc.	John Buse, MD, PhD Irl Hirsch, MD Luigi Meneghini, MD Bernard Zinman, MD
12:30pm - 2:00pm	Lunch Symposium B Getting to the Heart of Diabetic Dyslipidemia in High-Risk Patients: Clinical Dilemmas & Novel Approaches to Cardiovascular Risk Reduction Supported by an educational grant from Genentech, A Member of the Roche Group	Darren McGuire, MD Sunder Mudaliar, MD Jorge Plutzky, MD Jean-Claude Tardif, MD
2:15pm - 2:45pm	Elevated Serum Creatinine: Different Meaning in Different Settings?	George Bakris, MD
2:45pm - 3:15pm	CKD Endpoints in Clinical Trials: Guidance for Clinical Practice	Glenn Chertow, MD
3:15pm - 4:00pm	Afternoon Break/Exhibit Hall
4:00pm - 4:30pm	Alternative Therapies for HTN: Examining the Evidence	Robert Brook, MD
4:30pm - 5:30pm	Clinical Controversies in HTN Management: Expert Perspectives & Discussion	Moderator: George Bakris, MD Case Presenters & Discussants: Rajiv Agarwal, MD Raymond Townsend, MD William White, MD
5:30pm	Closing Remarks	George Bakris, MD
6:30pm - 8:30pm	Dinner Symposium A Obesity Management 2013: Expert Perspectives on the Clinical Impact of Novel & Emerging Therapies Supported by an educational grant from Novo Nordisk, Inc	Caroline Apovian, MD Robert Eckel, MD Ken Fujioka, MD Robert Kushner, MD
6:30pm - 8:30pm	Dinner Symposium B CV Outcomes for Oral & Incretin-Based Therapies: Examining Cutting-Edge Data & Clinical Implications for Patient Care This activity is supported by an educational grant from Takeda Pharmaceuticals International, Inc., US Region	George Bakris, MD William Cushman, MD Vivian Fonseca, MD William White, MD

Saturday, October 5, 2013

6:15am - 7:45am	Breakfast Symposium State-of-the-Art Advances in T2DM Management: Expert Analysis of New & Emerging GLP-1 Receptor Agonists Supported by an educational grant from Lilly USA, LLC	Thomas Blevins, MD Anne Peters, MD Carol Wysham, MD
8:00am - 8:10am	Opening Remarks	Robert Eckel, MD
8:10am - 9:00am	Keynote Session Brown Fat: Is It Important to Body Weight and Metabolic Risk in Humans?	C. Ronald Kahn, MD
9:00am - 9:30am	Metabolic Surgery 2013: Patient Selection and Outcomes	Francesco Rubino, MD
9:30am - 10:00am	Look AHEAD: Interpreting the Results for Clinical Practice	David Nathan, MD
10:00am - 10:15am	Morning Break
10:15am - 11:00am	Diet & Exercise: What's the Optimal Prescription?	Moderator: Robert Eckel, MD Presenters and Discussants: I-Min Lee, MD, ScD Barbara Millen, DPH, RD, RADA
11:00am - 11:30am	Clinical Management of Obesity-Related NAFLD	Samuel Klein, MD
11:30am - 11:50am	Obesity Medicine: Practical Pointers for Your Office or Clinic	Robert Kushner, MD
11:50am - 12:30pm	Clinical Challenges & Practical Strategies for Obesity Management *Where does obesity pharmacotherapy or surgery fit into the treatment algorithm for diabetes?* *When is it more important to treat the comorbidity vs. focus on weight loss?* *How much weight loss do you need to achieve to tackle comorbidities?*	Moderator: Robert Eckel, MD Discussants: C. Ronald Kahn, MD Samuel Klein, MD Robert Kushner, MD I-Min Lee, MD, ScD Barbara Millen, DPH, RD, RADA David Nathan, MD Francesco Rubino, MD
12:30pm	Closing Remarks	Robert Eckel, MD

Back to Top

A division of Tarsus Medical owned by Tarsus PLC

COPYRIGHT © 2018
Cardiometabolic Health Congress.
All Rights Reserved.

Responsive Medical Website Design and Medical Internet Marketing by www.webtomed.com